rs2274257
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003902.5(FUBP1):c.1042-8C>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0858 in 1,592,650 control chromosomes in the GnomAD database, including 7,084 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_003902.5 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FUBP1 | NM_003902.5 | c.1042-8C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000370768.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FUBP1 | ENST00000370768.7 | c.1042-8C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_003902.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0910 AC: 13835AN: 152070Hom.: 827 Cov.: 32
GnomAD3 exomes AF: 0.115 AC: 26778AN: 233514Hom.: 1987 AF XY: 0.112 AC XY: 14138AN XY: 126392
GnomAD4 exome AF: 0.0853 AC: 122811AN: 1440464Hom.: 6250 Cov.: 28 AF XY: 0.0860 AC XY: 61627AN XY: 716734
GnomAD4 genome AF: 0.0911 AC: 13859AN: 152186Hom.: 834 Cov.: 32 AF XY: 0.0979 AC XY: 7283AN XY: 74404
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at